Dr Michael Charlton, medical director of Intermountain Medical Center's Transplant Program talks about the new national guidelines issued this week to manage and treat the hepatitis C virus The new guidelines will have a complex algorithm for practitioners around the country to follow and see whats the right right treatment, for the right patients, for the right about of time.
AASLD/IDSA Launches up-to-date guidance for the treatment of hepatitis C
Online Expert Advice for Clinicians Treating Hepatitis C Now Available at HCVguidelines.org
Last week the American Association for the Study of Liver Diseases (AASLD) and the Infectious
Diseases Society of America (IDSA), in collaboration with the International Antiviral Society-
USA (IAS-USA), announced the launch of a new website,
HCVguidelines.org,
that will offer up-
to-date guidance for the treatment of hepatitis C virus (HCV) infection.
It is estimated that between 3 and 4 million Americans are infected with HCV and have chronic
liver disease as a result. The most recent generation of direct-acting antivirals has the potential
to cure most patients with HCV. However, the rapid
pace of drug development has left medical
providers and insurance companies unsure what the optimal treatments are. The guidance
provided through
HCVguidelines.org
will assist clinicians in using these and other treatments in
the care of their patients.
HCVguidelines.org
is the result of an ongoing collaboration between
the two medical
professional societies and IAS-USA.
New sections will be added, and the recommendations will be updated on a
regular basis as new information becomes available. An ongoing summary
of "recent changes" will also be available for readers who want to be
directed to updates and changes.
This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
- Home
- Newly Diagnosed With Hep C? Or Considering Treatment?
- All FDA Approved Drugs To Treat Hepatitis C
- Hepatitis C Genotypes and Treatment
- Mavyret (glecaprevir/pibrentasvir)
- Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir)
- Epclusa® (Sofosbuvir/Velpatasvir)
- Harvoni® (Ledipasvir/Sofosbuvir)
- VIEKIRA XR/VIEKIRA Pak
- Zepatier(Elbasvir/Grazoprevir)
- Cure - Achieving sustained virologic response (SVR) in hepatitis C
- HCV Liver Fibrosis
- FibroScan® Understanding The Results
- HCV Cirrhosis
- Staging Cirrhosis
- HCV Liver Cancer
- Risk Of Developing Liver Cancer After HCV Treatment
- Treating Elderly HCV Patients
- Fatty Liver Disease: NAFLD/NASH
- Current research articles on ailments that may be related to HCV
- Is There A Natural Way To Improve Liver Fibrosis?
- Can Food Or Herbs Interact With Conventional Medical Treatments?
Subscribe to:
Post Comments (Atom)
Where to get the new drug treatment today for hep c? What are the steps to follow? Is there a website that u could recommend
ReplyDeleteVisit your family doctor and ask them to direct you.
ReplyDeleteThe link below will help you get started.
Start Here